A continuous-time mathematical model and discrete approximations for the aggregation of β-Amyloid

References

• A.S. Ackleh, H.T. Banks, K. Deng, and S. Hu, Parameter estimation in a coupled system of nonlinear size-structured populations, Math. Biosci. Engin. 2 (2005), pp. 289–315.
   PubMed Web of Science ®Google Scholar
• A.S. Ackleh, J. Carter, K. Deng, Q. Huang, N. Pal, and X. Yang, Fitting a structured juvenile-Adult model for Green tree frogs to population estimates from capture-mark-recapture field data, Bull. Math. Biol. 74 (2012), pp. 641–665.
   PubMed Web of Science ®Google Scholar
• A.S. Ackleh, K. Deng, and X. Yang, Sensitivity analysis for a structured juvenile-adult model, Comput. Math. Appl. 64 (2012), pp. 190–200.
   Web of Science ®Google Scholar
• R.W. Atherton, R.B. Schainker, and E.R. Ducot, On the statistical sensitivity analysis of models for chemical kinetics, AZChE J. 21(3) (1975), pp. 441–448.
   Web of Science ®Google Scholar
• M. Bertsch, B. Franchi, N. Marcello, M.C. Tesi, and A. Tosin, Alzheimer's disease: a mathematical model for onset and progression, Math. Med. Biol. J. IMA 34(2) (2016), pp. 193–214.
   Web of Science ®Google Scholar
• L.M. Besser, D.P. Gill, S.E. Monsell, W. Brenowitz, D. Meranus, W. Kukull, and D.R. Gustafson, Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer's disease, Alzheimer Dis. Assoc. Disorders 28(1) (2014), pp. 36.
   PubMed Web of Science ®Google Scholar
• R.J.H. Beverton and S.J. Holt, On the Dynamics of Exploited Fish Populations, Fishery Investigations, Series II Volume XIX, Ministry of Agriculture, Fisheries and Food, 1957.
   Google Scholar
• K. Beyreuther and C.L. Masters, Amyloid precursor protein (APP) and beta a4 amyloid in the etiology of alzheimer's disease: precursor-Product relationships in the derangement of neuronal function, Brain Pathol. 1 (1991), pp. 241–251. Brain Pathol. 1, pp. 241–251.
   PubMed Web of Science ®Google Scholar
• M.F. Bishop and F.A. Ferrone, Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway, Biophys. J. 46(5) (1984), pp. 631–644.
   PubMed Web of Science ®Google Scholar
• J. Busciglio, D.H. Gabuzda, P. Matsudaira, and P.A. Yankner, Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells, Proc. Natl. Acad. Sci. USA 90 (1993), pp. 2092–2096.
   PubMed Web of Science ®Google Scholar
• V. Calvez, N. Lenuzza, D. Oelz, J.P. Deslys, P. Laurent, F. Mouthon, and B. Perthame, Size distribution dependence of prion aggregates infectivity, Math. Biosci. 217(1) (2009), pp. 88–99.
   PubMed Web of Science ®Google Scholar
• H. Caswell, Matrix Population Models, Sinauer, Sunderland, MA, Vol. 1, 2000.
   Google Scholar
• B. Caughey and P.T. Lansbury, Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders, Annu. Rev. Neurosci. 26 (2003), pp. 267–298.
   PubMed Web of Science ®Google Scholar
• F. Chiti and C.M. Dobson, Protein misfolding, functional amyloid, and human disease, Annu. Rev. Biochem. 75 (2006), pp. 333–366.
   PubMed Web of Science ®Google Scholar
• I.S. Ciuperca, M. Dumont, A. Lakmeche, P. Mazzocco, L. Pujo-Menjouet, H. Rezaei, and L.M. Tine, Alzheimer's disease and prion: an in vitro mathematical model, (2018).
   Google Scholar
• S.I. Cohen, M. Vendruscolo, M.E. Welland, C.M. Dobson, E.M. Terentjev, and T.P. Knowles, Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments, J. Chem. Phys. 135(6) (2011), pp. 08B615.
   Web of Science ®Google Scholar
• S.I.A. Cohen, M. Vendruscolo, C.M. Dobson, and T.P.J. Knowles, From macroscopic measurements to microscopic mechanisms of protein aggregation, J. Molecular Biol. 421(2–3) (2012), pp. 160–171.
   PubMed Web of Science ®Google Scholar
• C.M. Cowan, S. Quraishe, and A. Mudher, What is the pathological significance of tau oligomers?, Biochem. Soc. Trans. 40(4) (2012), pp. 693–697.
   PubMedGoogle Scholar
• D.L. Craft, L.M. Wein, and D.J. Selkoe, A mathematical model of the impact of novel treatments on the Aβ burden in the Alzheimer's brain, CSF and plasma, Bull. Math. Biol. 64(5) (2002), pp. 1011–1031.
   PubMed Web of Science ®Google Scholar
• M.A. Dayeh, G. Livadiotis, and S. Elaydi, A discrete mathematical model for the aggregation of β-Amyloid, PLoS ONE 13(5) (2018), p. e0196402. Available at https://doi.org/https://doi.org/10.1371/journal.pone.0196402.
   PubMed Web of Science ®Google Scholar
• E.P. Dougherty and H. Rabitz, Computational kinetics and sensitivity analysis of hydrogen-oxygen combustion, J. Chem. Phys. 72(12) (1980), pp. 6571–6586.
   Web of Science ®Google Scholar
• S. Elaydi, An Introduction to Difference Equations, 3rd ed., Springer, New York, NY, 2005.
   Google Scholar
• H. Engler, J. Prüss, and G.F. Webb, Analysis of a model for the dynamics of prions II, J. Math. Anal. Appl. 324(1) (2006), pp. 98–117.
   Web of Science ®Google Scholar
• S.T. Ferreira, M.N. Vieira, and F.G. De Felice, Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases, IUBMB Life 59 (2007), pp. 332–345.
   PubMed Web of Science ®Google Scholar
• B. Franchi and M.C. Tesi, A qualitative model for aggregation-fragmentation and diffusion of β-amyloid in Alzheimer's disease, Rend. Semin. Mat. Univ. Politec. Torino 70 (2012), pp. 75–84.
   Google Scholar
• P.E. Fraser, L.K. Duffy, M.B. O'Malley, J. Nguyen, H. Inouye, and D.A. Kirschner, Morphology and antibody recognition of synthetic beta-amyloid peptides, J. Neurosci. Res. 28 (1991), pp. 474–485.
   PubMed Web of Science ®Google Scholar
• D. Games, D. Adams, R. Alessandrini, R. Barbour, and P. Borthelette, Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein, Nature 373(6514) (1995), pp. 523.
   PubMed Web of Science ®Google Scholar
• C. Haass and D.J. Selkoe, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide, Nat. Rev. Mol. Cell. Biol. 8 (2007), pp. 101–112.
   PubMed Web of Science ®Google Scholar
• W. Hao and A. Friedman, Mathematical model on Alzheimer's disease, BMC Syst. Biol. 10 (2016), p. 108.
   PubMed Web of Science ®Google Scholar
• J.A. Hardy and D. Allisop, Amyloid deposition as the central event in the aetiology of Alzheimer's disease, Trends Pharmac 12 (1991), pp. 383–388. Trends in Pharmaca 12, 383–388.
   PubMed Web of Science ®Google Scholar
• J.A. Hardy and G.A. Higgins, Alzheimer's disease: the amyloid cascade hypothesis, Science 256 (1992), pp. 184–185.
   PubMed Web of Science ®Google Scholar
• D.M. Hartley, D.M. Walsh, C.P. Ye, T. Diehl, S. Vasquez, P.M. Vassilev, D.B. Teplow, and D.S.Selkoe, Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and neurotoxicity in cortical neurons, J. Neurosci. 19 (1999), pp. 8876–8884.
   PubMed Web of Science ®Google Scholar
• M. Helal, E. Hingant, L. Pujo-Menjouet, and G.F. Webb, Alzheimer's disease: analysis of a mathematical model incorporating the role of prions, J. Math. Biol. 69(5) (2014), pp. 1207–1235.
   PubMed Web of Science ®Google Scholar
• S.E. Hill, J. Robinson, G. Matthews, and M. Muschol, Amyloid protofibrils of lysozyme nucleate and grow via oligomer fusion, Biophys. J. 96(9) (2009), pp. 3781–3790.
   PubMed Web of Science ®Google Scholar
• L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, P. Jantzen, K. Wright, I. Saad, R.Mueller, D. Morgan, S. Sanders, C. Zehr, K.O. Campo, J. Hardy, C.M. Prada, C. Eckman, S. Younkin, K. Hsiao, and K. Duff, Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes, Nat. Med. 4 (1998), pp. 97–100.
   PubMed Web of Science ®Google Scholar
• K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole, Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice, Science 274 (1996), pp. 99–102.
   PubMed Web of Science ®Google Scholar
• C.R. Jack Jr, D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, P.S. Aisen, L.M. Shaw, P. Vemuri, H.J. Wiste, S.D. Weigand, and T.G. Lesnick, Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, Lancet Neur. 12(2) (2013), pp. 207–216.
   PubMed Web of Science ®Google Scholar
• H.G. Lee, G. Casadesus, X. Zhu, J.A. Joseph, G. Perry, and M.A. Smith, Perspectives on the amyloid-β cascade hypothesis, J. Alzheimer's Dis. 6 (2004), pp. 137–145.
   PubMed Web of Science ®Google Scholar
• F. Kametani and M. Hasegawa, Reconsideration of Amyloid hypothesis and tau hypothesis in Alzheimer's Disease, Front. Neurosci. 12 (2018), p. 25. 1–21.
   PubMed Web of Science ®Google Scholar
• K. Kepp, Ten challenges of the amyloid hypothesis of alzheimer's disease, J. Alzheimer's Dis.55 (2017), pp. 447–457.
   PubMed Web of Science ®Google Scholar
• W.L. Klein, G.A. Krafft, and C.E. Finch, Targeting small β-Amyloid oligomers: the solution to an Alzheimer's disease conundrum?, Trends Neurosci. 24 (2001), pp. 219–224.
   PubMed Web of Science ®Google Scholar
• T.P. Knowles, C.A. Waudby, G.L. Devlin, S.I. Cohen, and A. Aguzzi, An analytical solution to the kinetics of breakable filament assembly, Science 326(5959) (2009), pp. 1533–1537.
   PubMed Web of Science ®Google Scholar
• S. Kumar and J. Walter, Phosphorylation of amyloid beta (Aβ) peptides : A trigger for formation of toxic aggregates in Alzheimer's disease, AGING 3(8) (2011).
   PubMedGoogle Scholar
• E. Kwessi, S. Elaydi, G.B. Dennis, and G. Livadiotis, Nearly exact discretization of single species, Nat. Res. Model. 31(4) (2018), p. e12167.
   Web of Science ®Google Scholar
• K.J. Laidler, Chemical Kinetics, 3rd ed., Harper & Row, New York, NY, 1987. p. 42.
   Google Scholar
• F.M. Laferla, K.N. Green, and S. Oddo, Intracellular amyloid-beta in Alzheimer's disease, Nat. Rev. Neurosci. 8 (2007), pp. 499–509.
   PubMed Web of Science ®Google Scholar
• M.P. Lambert, A.K. Barlow, B.A. Chromy, C. Edwards, R. Freed, M. Liosatos, T.E. Morgan, I.Rozovsky, and B. Trommer, Diffusible, nonfibrillar ligands derived from ABeta-Amyloid1-42 are potent central nervous system neurotoxins, Proc. Natl. Acad. Sci. USA 95 (1998), pp. 6448–6453.
   PubMed Web of Science ®Google Scholar
• H.G. Lee, P.I. Moreira, X. Zhu, M.A. Smith, and G. Perry, Staying connected: synapses in Alzheimer disease, Am. J. Pathol 165 (2004), pp. 1461–1464.
   PubMed Web of Science ®Google Scholar
• S. Lesne, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, M. Gallagher, and K.H. Ashe, A specific amyloid-beta protein assembly in the brain impairs memory, Nature 440 (2006), pp. 352–357.
   PubMed Web of Science ®Google Scholar
• C. Letellier, S. Elaydi, L.A. Aguirre, and A. Alaoui, Difference equation versus differential equations, a possible equivalence for the Rössler system, Physica D 195 (2004), pp. 29–49.
   Web of Science ®Google Scholar
• S. Linse, Monomer-dependent secondary nucleation in amyloid formation, Biophys. Rev. 9(4) (2017), pp. 329–338.
   PubMedGoogle Scholar
• A. Lomakin, D.B. Teplow, D.A. Kirschner, and G.B. Benedek, Kinetic theory of fibrillogenesis of amyloid β-protein, Proc. Natl. Acad. Sci. USA. 94 (1997), pp. 7942–7947.
   PubMed Web of Science ®Google Scholar
• J. Masel and V.A. Jansen, Designing drugs to stop the formation of prion aggregates and other amyloids, Biophys. Chem. 88(1–3) (2000), pp. 47–59.
   PubMed Web of Science ®Google Scholar
• M.P. Mattson, B. Cheng, D. David, K. Bryant, I. Lieberburg, and R.E. Rydel, β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci. 12 (1992), pp. 376–389.
   PubMed Web of Science ®Google Scholar
• R.E. Mickens, Applications of Non-standard Finite Difference Schemes, World Scientific, River Edge, NJ, 2000.
   Google Scholar
• R.E. Mickens, Nonstandard finite difference schemes for differential equations, J. Differ. Equ. Appl. 8(9) (2002), pp. 823–947.
   Web of Science ®Google Scholar
• G. Morris, I. Clark, and B. Vissel, Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease, Acta Neuropath Communi. 2 (2014), p. 135. 1–40.
   PubMed Web of Science ®Google Scholar
• L. Mucke and D.J. Selkoe, Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction, Cold Spring Harb. Perspect. Med. 2 (2012), p. a006338.
   PubMed Web of Science ®Google Scholar
• H. Naiki and K. Nakakuki, First-order kinetic model of Alzheimer's β-amyloid fibril extension in vitro, Lab. Invest. 74 (1996), pp. 374–383.
   PubMed Web of Science ®Google Scholar
• K.M. Rodrigue, K.M. Kennedy, and D.C. Park, Beta-amyloid deposition and the aging brain, Neuropsychol Rev. 19 (2009), pp. 436–450.
   PubMed Web of Science ®Google Scholar
• C.L. Ni, H.P. Shi, H.M. Yu, Y.C. Chang, and Y.R. Chen, Folding stability of amyloid-beta 40 monomer is an important determinant of the nucleation kinetics in fibrillization, FASEB J. 25 (2011), pp. 1390–1401.
   PubMed Web of Science ®Google Scholar
• J.M. Ortega, Matrix Theory: A Second Course, University Series in Mathematics, Springer, New York, NY, 1987.
   Google Scholar
• M.M. Pallitto and R.M. Murphy, A mathematical model of the kinetics of β-Amyloid fibril growth from the denatured state, Biophys. J. 81 (2001), pp. 1805–1822.
   PubMed Web of Science ®Google Scholar
• C.J. Pike, D. Burdick, A.J. Walencewicz, C.G. Glabe, and C.W. Cotman, Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci. 13 (1993), pp. 1676–1687.
   PubMed Web of Science ®Google Scholar
• C.J. Proctor, D. Boche, D.A. Gray, and J.A. Nicoll, Investigating interventions in Alzheimer's disease with computer simulation models, PloS One 8(9) (2013), pp. e73631.
   PubMed Web of Science ®Google Scholar
• J. Pruss, L. Pujo-Menjouet, G. Webb, and R. Zacher, Analysis of a model for the dynamics of prions, Discrete Contin. Dyn. Syst. Ser. B 6(1) (2006), pp. 225–235.
   Web of Science ®Google Scholar
• I.K. Puri and L. Li, Mathematical modeling for the pathogensis of Alzheimer's disease, Plosone 5(12) (2010), pp. c15176.
   Web of Science ®Google Scholar
• D. Purves, G. Augustine, D. Fitzpatrick, W.C. William, L. Anthony-Samuel, L.E. White, R.D. Mooney, and M.L. Platt, Neuroscience, 5th ed., Sinauer Associates, Sunderland, MA, 2012. p. 713–
   Google Scholar
• M. Sakono and T. Zako, Amyloid oligomers: formation and toxicity of Ab oligomers, FEBS 277 (2010), pp. 1348–1358.
   PubMed Web of Science ®Google Scholar
• B. Seilheimer, B. Bohrmann, L. Bondolfi, F. Muller, D. Stuber, and H. Dobeli, The toxicity of the Alzheimer's β-amyloid peptide correlates with a distinct fiber morphology, J. Struct. Biol. 119 (1997), pp. 59–71.
   PubMed Web of Science ®Google Scholar
• D.J. Selkoe, The molecular pathology of Alzheimer's disease, Neuron 6 (1991), pp. 487–498.
   PubMed Web of Science ®Google Scholar
• D.J. Selkoe and J. Hardy, The Amyloid hypothesis of Alzheimer's disease at 25 years, EMBO Molecular Med. 8 (2016), pp. 595–608.
   PubMed Web of Science ®Google Scholar
• S.L. Shammas, G.A. Gonzalo, S. Kumar, M. Kjaergaard, M.H. Horrocks, N. Shivji, E. Mandelkow, E. Knowles, and D. Klenerman, A mechanistic model of tau amyloid aggregation based on direct observational oligomers, Nat. Commun. 6 (2015), pp. 7025.
   PubMed Web of Science ®Google Scholar
• L.K. Simmons, P.C. May, K.J. Tomaselli, R.E. Rydel, K.S. Fuson, E.F. Brigham, S. Wright, I.Lieberburg, G.W. Becker, D.N. Brems, and W.Y. Li, Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol. 45 (1994), pp. 373–379.
   PubMed Web of Science ®Google Scholar
• P.F. Verhulst, Notice sur la loi que la population poursuit dans son accroissement, Corresp. Math. Phys. 10 (1838), pp. 113–121. Retrieved 3 December 2014.
   Google Scholar
• D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J.Selkoe, Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo, Nature 416 (2002), pp. 535–539.
   PubMed Web of Science ®Google Scholar
• H.W. Wang, J.F. Pasternak, H. Kuo, H. Ristic, M.P. Lambert, B. Chromy, K.L. Viola, W.L. Klein, W.B. Stine, G.A. Krafft, and B.L. Trommer, Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus, Brain Res. 924 (2002), pp. 133–140.
   PubMed Web of Science ®Google Scholar
• R.V. Ward, K.H. Jennings, R. Jepras, W. Neville, D.E. Owen, J. Hawkins, G. Christie, J.B. Davis, A. George, E.H. Karran, and D.R. Howlett, Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide, Biochem. J. 348 (2000), pp. 137–144.
   PubMed Web of Science ®Google Scholar
• B.A. Yankner, L.K. Duffy, and D.A. Kirschner, Neurotrophic and neurotoxic effects of amyloid b-protein: reversal by tachykinin neuropeptides, Science J. 250 (1990), pp. 279–282.
   PubMed Web of Science ®Google Scholar
• Y. Yoshiike, R. Minai, Y. Matsuo, Y.R. Chen, T. Kimura, and A. Takashima, Amyloid oligomer conformation in a group of natively folded proteins, PLoS One 3 (2008), pp. e3235.
   PubMed Web of Science ®Google Scholar